title: Immunohistochemical estimation of cell cycle phase in laryngeal neoplasia.
abstract: We previously developed an immunohistochemical method for estimating cell cycle state and phase in tissue samples, including biopsies that are too small for flow cytometry. We have used our technique to examine whether primary abnormalities of the cell cycle exist in laryngeal neoplasia. Antibodies against the markers of cell cycle entry, minichromosome maintenance protein-2 (Mcm-2) and Ki67, and putative markers of cell cycle phase, cyclin D1 (G1-phase), cyclin A (S-phase), cyclin B1 (G2-phase) and phosphohistone H3 (Mitosis) were applied to paraffin-embedded sections of normal larynx (n = 8), laryngeal dysplasia (n = 10) and laryngeal squamous cell carcinoma (n = 10). Cells expressing each marker were determined as a percentage of total cells, termed the labelling index (LI), and as a percentage of Mcm-2-positive cells, termed the labelling fraction (LF). The frequency of coexpression of each putative phase marker was investigated by confocal microscopy. There was a correlation between Mcm-2 and Ki67 LIs (rho = 0.93) but Mcm-2 LIs were consistently higher. All cells expressing a phase marker coexpressed Mcm-2, whereas Ki67 was not expressed in a proportion of these cells. The putative phase markers showed little coexpression. Labelling index values increased on progression from normal larynx through laryngeal dysplasia to squamous cell carcinoma for Mcm-2 (P = 0.001), Ki67 (P = 0.0002), cyclin D1 (P = 0.015), cyclin A (P = 0.0001) and cyclin B1 (P = 0.0004). There was no evidence of an increase in the LF for any phase marker. Immunohistochemistry can be used to estimate cell cycle state and phase in laryngeal biopsies. Our data argues against primary cell cycle phase abnormalities in laryngeal neoplasia.
authors.affiliation: MRC Cancer Cell Unit, Hutchison/MRC Research Centre, Cambridge CB2 2XZ, UK.
authors.forename: P
authors.initials: P
authors.lastname: Chatrath
authors.forename: I S
authors.initials: IS
authors.lastname: Scott
authors.forename: L S
authors.initials: LS
authors.lastname: Morris
authors.forename: R J
authors.initials: RJ
authors.lastname: Davies
authors.forename: K
authors.initials: K
authors.lastname: Bird
authors.forename: S L
authors.initials: SL
authors.lastname: Vowler
authors.forename: N
authors.initials: N
authors.lastname: Coleman
mesh_terms: D014408:Biomarkers, Tumor / Q000096:biosynthesis; D002294:Carcinoma, Squamous Cell / Q000473:pathology*; D002453:Cell Cycle; D018797:Cell Cycle Proteins / Q000096:biosynthesis; D016193:G1 Phase; D016195:G2 Phase; D006801:Humans; D007150:Immunohistochemistry; D019394:Ki-67 Antigen / Q000096:biosynthesis; D007822:Laryngeal Neoplasms / Q000473:pathology*; D018613:Microscopy, Confocal / Q000379:methods; D064111:Minichromosome Maintenance Complex Component 2; D008938:Mitosis; D009687:Nuclear Proteins / Q000096:biosynthesis; D016612:Paraffin Embedding; D016196:S Phase; D012680:Sensitivity and Specificity
chemical_list: D014408:Biomarkers, Tumor; D018797:Cell Cycle Proteins; D019394:Ki-67 Antigen; D009687:Nuclear Proteins; C084859:MCM2 protein, human; D064111:Minichromosome Maintenance Complex Component 2